Comparative effectiveness of individualised homoeopathic medicines in lm potencies and centesimal potencies for the management of irritable bowel syndrome: a prospective randomized clinical study
Trial Snapshot
- Phase
- Phase 2
- Status
- Not yet recruiting
- Enrollment
- 84
- Locations
- 1
- Primary Endpoint
- Assessment of increase or decrease in IBS-QOL questionnaire total score in patient
Study Overview
Brief Summary
The study will explore not only the symptomatic relief of IBS using IBS-QOL scores and IBS-SSS scores provided by the respective potencies of Homoeopathic medicine but also consider broader aspects such as quality of life, psychological well-being, and patient satisfaction. Through a comprehensive and randomized approach, this research seeks to enhance our understanding of homoeopathic approaches to IBS but also provide evidence-based guidance for practitioners in choosing between LM and centesimal potencies, thus optimizing individualized treatment strategies for patients suffering from this challenging condition.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Masking
- None
Eligibility Criteria
- Ages
- 18.00 Year(s) to 65.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Patients suffering from IBS as per Rome IV diagnostic criteria b.
- •Both sexes c.
- •Age 18-65 years d.
- •Patients willing to participate in the study and giving written informed consent.
- •Ability to Understand Bengali or Hindi or English.
Exclusion Criteria
- •Any major gastrointestinal surgery in the last 6 months b.
- •Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or lifethreatening illness affecting the quality of life or any organ failure.
- •Currently receiving standard therapy for IBS and/ or homoeopathic treatment for any chronic condition(s) d.
- •Pregnant and lactating women e.
- •Self-reported immune compromised conditions f.
- •Substance abuse and/or dependence g.
- •Patients who are too sick for consultation.
Outcomes
Primary Outcomes
Assessment of increase or decrease in IBS-QOL questionnaire total score in patient
Time Frame: Baseline and every month up to 6 months of treatment.
suffering from Irritable Bowel Syndrome
Time Frame: Baseline and every month up to 6 months of treatment.
Secondary Outcomes
- Assessment of increase or decrease in IBS-SSS questionnaire total score in patient(suffering from Irritable Bowel Syndrome)
Investigators
Subhrajit Paul
National Institute of Homoeopathy